-
EP4259651
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4259651
| EP4259651 - COMPOSITIONS AND METHODS FOR CELLULAR IMMUNOTHERAPY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.09.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 25.06.2022 | ||
| Former | unknown Status updated on 21.01.2022 | Most recent event Tooltip | 16.02.2024 | Change: Validation states | published on 20.03.2024 [2024/12] | 16.02.2024 | Change - extension states | published on 20.03.2024 [2024/12] | Applicant(s) | For all designated states Fred Hutchinson Cancer Center 1100 Fairview Avenue North Seattle, WA 98109 / US | [2023/42] | Inventor(s) | 01 /
SCHMITT, Thomas M. Seattle, Washington 98107 / US | 02 /
MCAFEE, Megan S. Wayland, Massachusetts 01778 / US | 03 /
CHAPUIS, Aude G. Seattle, Washington 98117 / US | [2023/42] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2023/42] | Application number, filing date | 21841111.4 | 14.12.2021 | [2023/42] | WO2021US63409 | Priority number, date | US202063125347P | 14.12.2020 Original published format: US 202063125347 P | [2023/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022132836 | Date: | 23.06.2022 | Language: | EN | [2022/25] | Type: | A2 Application without search report | No.: | EP4259651 | Date: | 18.10.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.06.2022 takes the place of the publication of the European patent application. | [2023/42] | Search report(s) | International search report - published on: | EP | 04.08.2022 | Classification | IPC: | C07K14/725, C07K14/705, A61K35/17, A61P35/00 | [2023/42] | CPC: |
C07K14/70517 (EP);
A61K39/4611 (EP,US);
A61K39/4632 (EP,US);
A61K39/464453 (EP,US);
A61K39/464486 (EP,US);
A61P35/00 (EP);
C07K14/7051 (EP);
C07K14/70521 (EP);
C07K14/70528 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/42] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ZELLULÄREN IMMUNTHERAPIE | [2023/42] | English: | COMPOSITIONS AND METHODS FOR CELLULAR IMMUNOTHERAPY | [2023/42] | French: | COMPOSITIONS ET MÉTHODES POUR L'IMMUNOTHÉRAPIE CELLULAIRE | [2023/42] | Entry into regional phase | 11.07.2023 | National basic fee paid | 11.07.2023 | Designation fee(s) paid | 11.07.2023 | Examination fee paid | Examination procedure | 11.07.2023 | Examination requested [2023/42] | 11.07.2023 | Date on which the examining division has become responsible | 08.02.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9623814 (CELL GENESYS INC [US]); | [A]WO2018151817 (UNUM THERAPEUTICS INC [US]); | [A]WO2020223537 (PACT PHARMA INC [US]); | [E]WO2022016114 (INSTILL BIO UK LTD [GB], et al); | by applicant | US5283173 | US5420032 | US5468614 | US2004002092 | US2004087025 | US6833252 | US2006078552 | US2006153826 | US2006206949 | US2007117128 | WO2010084158 | US2011189141 | US2011243972 | US2011301073 | US8119772 | WO2013025779 | WO2013071154 | WO2014031687 | US2014068797 | US8697359 | US2014186843 | WO2015071474 | WO2016022400 | WO2016040724 | WO2016054638 | WO2016134333 | WO2017021526 | US9574000 | WO2017112944 | WO2017193104 | WO2018058002 | WO2018090057 | WO2018170338 | WO2019178427 |